(Q47712229)

English

Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

author name string

C M Cabrera

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

P Jiménez

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

A Concha

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

F Garrido

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

F Ruiz-Cabello

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

Tissue Antigens

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

63

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

446-452

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

The PML nuclear bodies: actors or extras?

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

A role for PML and the nuclear body in genomic stability

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Intracellular localization of proteasomal degradation of a viral antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

The ubiquitin-proteasome pathway: on protein death and cell life

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

SUMO-1: wrestling with a new ubiquitin-related modifier.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Structure and Function in the Nucleus

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Role and fate of PML nuclear bodies in response to interferon and viral infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Proto-oncogene PML controls genes devoted to MHC class I antigen presentation

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

The puzzling multiple lives of PML and its role in the genesis of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Impaired immunoproteasome assembly and immune responses in PA28-/- mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Escape from host-antitumor immunity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-2815.2004.00204.X

21 January 2018

Identifiers

10.1111/J.0001-2815.2004.00204.X

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15104675

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47712229&oldid=2166683091"